1,378 Shares in Intuitive Surgical, Inc. $ISRG Acquired by Aventura Private Wealth LLC

Aventura Private Wealth LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,378 shares of the medical equipment provider’s stock, valued at approximately $780,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Holos Integrated Wealth LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Kilter Group LLC purchased a new position in shares of Intuitive Surgical in the second quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical in the third quarter worth approximately $27,000. Caitlin John LLC bought a new stake in Intuitive Surgical during the third quarter valued at approximately $30,000. Finally, KERR FINANCIAL PLANNING Corp purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $33,000. 83.64% of the stock is owned by institutional investors.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Fundamentals remain strong — Intuitive reported an earnings beat and double‑digit revenue growth in its latest quarter, supporting the company’s long‑term growth thesis and valuation premium. Bull of the Day: Intuitive Surgical (ISRG)
• Positive Sentiment: Prominent bullish mentions — coverage including a “Bull of the Day” piece and a Jim Cramer mention keep ISRG on the buy/hold radar for growth investors, which can support buying interest after negative headlines. Jim Cramer Analyzed 5 Stocks
• Neutral Sentiment: Comparative analyses and sector commentary (head‑to‑head pieces) provide context but no immediate catalyst; these may influence longer‑term positioning rather than intraday moves. Head‑To‑Head Analysis: Lombard Medical & Intuitive Surgical
• Negative Sentiment: FDA safety flag on stapler devices — regulators have flagged safety concerns and advised halting affected devices, which is a near‑term operational and reputational risk that likely pressured the stock. FDA Flags Safety Concern Over Intuitive Surgical Stapler
• Negative Sentiment: Company warning and reported death related to stapler reloads — Intuitive issued warnings after at least one reported death, increasing legal, recall and adoption‑risk concerns for affected products. Intuitive warns on surgical stapler reloads with one death reported
• Negative Sentiment: Broader quality and cybersecurity scrutiny — reporting highlights recalls and other operational snags (including cyber incidents), which amplify investor uncertainty about near‑term execution and regulatory exposure. From Cyber Criminals to Recalls: Inside Intuitive Surgical’s Newest Snag
• Negative Sentiment: Technical weakness — the stock recently formed a “death cross” (50‑day moving average crossing below the 200‑day), which can trigger momentum selling from technical traders even if fundamentals remain solid. Intuitive Surgical Stock Just Flashed A Death Cross

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the sale, the senior vice president owned 1,613 shares in the company, valued at approximately $782,321.13. This trade represents a 28.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 32,943 shares of company stock worth $17,279,568 in the last quarter. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on ISRG shares. Truist Financial increased their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research report on Thursday, December 18th. Royal Bank Of Canada upped their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. Finally, TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical Price Performance

ISRG opened at $477.76 on Friday. The firm has a fifty day moving average price of $502.83 and a 200 day moving average price of $512.65. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $603.88. The stock has a market cap of $169.67 billion, a P/E ratio of 60.55, a P/E/G ratio of 3.70 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.